Commentary: Politics of affordable insulin

BMJ (Online)

Volumn 343, Issue 7823, 2011, Pages

  Gale, Edwin A M ^a   Yudkin, John S ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; METFORMIN; SULFONYLUREA;

DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; SOCIOECONOMICS; UNITED KINGDOM; ARTICLE; ECONOMICS; POLITICS;

DIABETES MELLITUS, TYPE 2; DRUG COSTS; DRUG INDUSTRY; HUMANS; INSULIN; POLITICS;

EID: 84859004910     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d5675     Document Type: Note

References (13)

1. World Health Organization. Unedited report of the 18th expert committee on the selection and use of essential medicines, 21st-25th March 2011, Accra, Ghana. www.who.int/selection-medicines/Complete-UNEDITED-TRS-18th.pdf.
2. National Collaborating Centre for Chronic Conditions. Type 2 diabetes. National clinical guidance for management in primary and secondary care (update). 2008. http://nice.org.uk/nicemedia/pdf/CG66GullGuideline0509.pdf.
3. 18th Expert Committee on the Selection and Use of Essential Medicines. Review of the evidence comparing insulin (human or animal) with analogue insulins. 2011. www.who.int/selection-medicines/committees/expert/18/ applications/Insulin-review.pdf.
4. Gale EAM for the UK Trial Group. A randomised controlled trial comparing insulin lispro with soluble insulin in patients with type 1 diabetes on intensified insulin therapy. Diab Med 2000;17:209-14.
5. Hauber A, Gale EAM. The market in diabetes. Diabetologia 2006;49:247-52. (Pubitemid 43185392)
6. Currie CJ, Peters JR, Evans M. Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008. Diab Med 2010;27:744-5.
7. Diabetes drugs "driving rise in NHS drugs bill." BBC News 2011. Aug 24. www.bbc.co.uk/go/em/fr/-/news/health-14650107.
8. HAI Global. Life-saving insulin largely unaffordable. A one day snapshot of the price of insulin across 60 countries. www.haiweb.org/medicineprices/ 07072010/Global-briefing-note-FINAL.pdf.
9. NovoNordisk. Novo Nordisk's LEAD initiative-leadership for education and access to diabetes care. www.novonordisk.com/sustainability/News/2001-11- backgrounder-lead-uk.asp.
10. Hope Worldwide. Eli Lilly: providing life for children. www.hopeww.org/NetCommunity/Page.aspx?pid=1595.
11. Beran D, Yudkin JS. Diabetes care in sub-Saharan Africa. Lancet 2006;368:1689-95. (Pubitemid 46070151)
12. Yudkin JS, Richter B, Gale EAM. Intensive treatment of hyperglycaemia: whose agenda? Lancet 2011;377:1220-2.
13. Prequalification programme. A United Nations programme managed by WHO. WHO, 2009. http://apps.who.int/prequal/.